Bristol Myers Squibb BMY
NYSE BMY
$62.93 -0.50 (-0.79%)
At close: Nov 16, 2026 · 4:00 PM EST

Bristol Myers Squibb (BMY) Receivables (2009 - 2026)

Updated

Bristol Myers Squibb (BMY) reported Receivables of $10.72 billion for Q3 2026, down 18.9% from $13.22 billion a year earlier but up 0.6% from the prior quarter.

Analysis

Bristol Myers Squibb (BMY) Receivables (2009 - 2026) Analysis & Trends

At the end of FY2025, Bristol Myers Squibb posted Receivables of $13.24 billion, up 6.0% from FY2024.

  • Receivables has a five-year compound annual growth rate of 6.2% (FY2020 to FY2025).
  • By year, Receivables came in at $12.48 billion in FY2024 (-3.7%), $12.96 billion in FY2023 (+11.5%), $11.62 billion in FY2022 (+8.0%) and $10.76 billion in FY2021 (+10.0%).
  • Five-year quarterly Receivables spans a low of $9.73 billion in Q4 2021 and a high of $13.22 billion in Q3 2025.
  • Year over year, Receivables has now declined in each of the last three quarters, with an average decline of 5.2% over the last eight quarters.
  • The high point for year-over-year Receivables in five years was Q1 2023 (growth of 24.2%); the low point was Q3 2026 (a decline of 18.9%).
  • Per Business Quant data, the three quarters before Q3 2026 came in at $10.66 billion (Q2 2026), $10.79 billion (Q1 2026) and $11.61 billion (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 25.23 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 18.99 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 13.51 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 12.74 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn 16.16 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 10.35 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 5.01 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 14.19 Bn
10 Bristol Myers Squibb 128.63 Bn 83.82 Bn 8.92 Bn 10.72 Bn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 10.72 Bn
Jun 30, 2026 10.66 Bn
Mar 31, 2026 10.79 Bn
Dec 31, 2025 11.61 Bn
Sep 30, 2025 13.22 Bn
Jun 30, 2025 13.12 Bn
Mar 31, 2025 12.54 Bn
Dec 31, 2024 11.13 Bn
Sep 30, 2024 12.74 Bn
Jun 30, 2024 13.10 Bn
Mar 31, 2024 12.07 Bn
Dec 31, 2023 11.34 Bn
Sep 30, 2023 12.20 Bn
Jun 30, 2023 12.10 Bn
Mar 31, 2023 12.25 Bn
Dec 31, 2022 10.39 Bn
Sep 30, 2022 11.21 Bn
Jun 30, 2022 10.52 Bn
Mar 31, 2022 9.87 Bn
Dec 31, 2021 9.73 Bn
API Access

Bristol Myers Squibb Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables&ticker=BMY&period=max&api_key=YOUR_API_KEY